Abstract
Small RNA molecules, including small interfering RNA (siRNA) and micro RNA (miRNA), have rapidly emerged as important regulators of gene expression. Recent articles have demonstrated RNA mediated complex induced transcriptional gene silencing (TGS) occurring in the nucleus. Originally the small RNA mediated TGS pathway has been reported in yeast and plants, currently a number of articles strongly suggest that this newly established gene silencing mechanism is present in mammals. RNA mediated TGS has been reported for various human promoters including inhibition of tumor susceptibility genes, X-chromosome inactivation and suppression of human chemokine receptor. Small RNAs can inhibit human viral infection through the TGS pathway. Prolonged HIV-1 transcriptional gene silencing by an RNA duplex targeting a sequence located within the HIV-1 promoter has been reported initially using a susceptible adherent cell line model and recently prolonged suppression of productive HIV-1 infection in a T-cell line model has been demonstrated by a retrovirally delivered short-hairpin RNA (shRNA) targeting the same region. RNA mediated gene silencing in HIV-1 infection can induce heterochromatin (closed) structure in the promoter regions, which is consistent to those changes seen in studies of various RNA directed TGS in various human promoter regions. More recent observations suggest transcriptional activation can be induced through RNA duplexes targeting the human promoter of E-cadherin, p21 and the progesterone receptor. Although the precise mechanisms of how RNA mediated transcriptional gene silencing or activation functions has yet to be elucidated, this review describes linkage of small RNA mediated gene regulation and induction of epigenetic regulation in the promoter region in mammals.
Keywords: Transcriptional gene silencing (TGS), siRNA/shRNA, RNAi, Heterochromatin formation, HIV-1
Current Topics in Medicinal Chemistry
Title: Transcriptional Regulation by Promoter Targeted RNAs
Volume: 9 Issue: 12
Author(s): Kazuo Suzuki and Anthony D. Kelleher
Affiliation:
Keywords: Transcriptional gene silencing (TGS), siRNA/shRNA, RNAi, Heterochromatin formation, HIV-1
Abstract: Small RNA molecules, including small interfering RNA (siRNA) and micro RNA (miRNA), have rapidly emerged as important regulators of gene expression. Recent articles have demonstrated RNA mediated complex induced transcriptional gene silencing (TGS) occurring in the nucleus. Originally the small RNA mediated TGS pathway has been reported in yeast and plants, currently a number of articles strongly suggest that this newly established gene silencing mechanism is present in mammals. RNA mediated TGS has been reported for various human promoters including inhibition of tumor susceptibility genes, X-chromosome inactivation and suppression of human chemokine receptor. Small RNAs can inhibit human viral infection through the TGS pathway. Prolonged HIV-1 transcriptional gene silencing by an RNA duplex targeting a sequence located within the HIV-1 promoter has been reported initially using a susceptible adherent cell line model and recently prolonged suppression of productive HIV-1 infection in a T-cell line model has been demonstrated by a retrovirally delivered short-hairpin RNA (shRNA) targeting the same region. RNA mediated gene silencing in HIV-1 infection can induce heterochromatin (closed) structure in the promoter regions, which is consistent to those changes seen in studies of various RNA directed TGS in various human promoter regions. More recent observations suggest transcriptional activation can be induced through RNA duplexes targeting the human promoter of E-cadherin, p21 and the progesterone receptor. Although the precise mechanisms of how RNA mediated transcriptional gene silencing or activation functions has yet to be elucidated, this review describes linkage of small RNA mediated gene regulation and induction of epigenetic regulation in the promoter region in mammals.
Export Options
About this article
Cite this article as:
Suzuki Kazuo and Kelleher D. Anthony, Transcriptional Regulation by Promoter Targeted RNAs, Current Topics in Medicinal Chemistry 2009; 9 (12) . https://dx.doi.org/10.2174/156802609789630875
DOI https://dx.doi.org/10.2174/156802609789630875 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Chemopreventive and Chemotherapeutic Potentials of Tea Polyphenols
Current Pharmaceutical Biotechnology Expression and Function of the Endocannabinoid System in Glial Cells
Current Pharmaceutical Design Zebrafish as a Model System to Screen Radiation Modifiers
Current Genomics Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors
Current Neuropharmacology Targeting Hsp90 in Non-Cancerous Maladies
Current Topics in Medicinal Chemistry Nutrition in Allogeneic Stem Cell Transplantion - Clinical Guidelines and Immunobiological Aspects
Current Pharmaceutical Biotechnology Synthesis and Biological Activity of Some New N1-(4-oxoquinolin-6-yl) amidrazones
Letters in Organic Chemistry Editorial [Hot Topic: New Antidepressant Drugs: Beyond Monoaminergic Mechanisms (Executive Editors: Cecilio Alamo and Francisco Lopez-Munoz)]
Current Pharmaceutical Design Patent Analysis as a Tool for Research Planning: Study on Natural Based Therapeutics Against Cancer Stem Cells
Recent Patents on Anti-Cancer Drug Discovery TNFα as Therapeutic Target: New Drugs, More Applications
Current Drug Targets - Inflammation & Allergy Chemokine-Chemokine Receptor Network in Immune Cell Trafficking
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Natural Terpenoids Against Female Breast Cancer: A 5-year Recent Research
Current Medicinal Chemistry Implication for Thiazolidinediones (TZDs) as Novel Potential Anti- Inflammatory Drugs
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Novel Approaches Towards Designing of Isoform-Selective Inhibitors Against Class II Histone Deacetylases: The Acute Requirement for Targetted Anticancer Therapy
Current Topics in Medicinal Chemistry Metabolic Targeting of Cancers: From Molecular Mechanisms to Therapeutic Strategies
Current Medicinal Chemistry A Review of Ruthenium Complexes Activities on Breast Cancer Cells
Mini-Reviews in Medicinal Chemistry Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis
Current Cancer Drug Targets Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation
Recent Patents on CNS Drug Discovery (Discontinued) Targeting the Cancer-Stroma Interaction: A Potential Approach for Pancreatic Cancer Treatment
Current Pharmaceutical Design Analysis and Validation of Differentially Expressed MicroRNAs with their Target Genes Involved in GLP-1RA Facilitated Osteogenesis
Current Bioinformatics